RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

32 hedge funds and large institutions have $16.3M invested in Rein Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PM
1
Prosight Management
Texas
$1.32M
2
SPC
2
Sigma Planning Corp
Michigan
$752K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$814K
4
GS
4
Gagnon Securities
New York
$254K
5
NFSG
5
Newbridge Financial Services Group
Florida
$88.5K

Top Sellers

1
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$4.97M
2
KC
2
Kepos Capital
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.53M
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$28K
5
WAM
5
Warberg Asset Management
Illinois
$35.4K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$1.01K -$25 -7 -2%
TRCT
27
Tower Research Capital (TRC)
New York
$860 -$12.8K -3,621 -94%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$825 – – –
HCP
29
Hexagon Capital Partners
Arkansas
$754 – – –
GPFA
30
Game Plan Financial Advisors
Ohio
$89 – – –
KC
31
Kepos Capital
New York
– -$294K -106,000 Closed
UBS Group
32
UBS Group
Switzerland
– -$8.71K -3,145 Closed
1
2